Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Mabtas 500 mg Solution for Infusion:
Mabtas 500 mg Solution for Infusion is a medication used in the treatment of various conditions such as non-Hodgkin lymphoma (NHL), rheumatoid arthritis, chronic lymphocytic leukemia (blood cancer), granulomatosis with polyangiitis, and microscopic polyangiitis.
Administered as an infusion under the supervision of a specialist, the dosage and frequency of Mabtas 500 mg Solution for Infusion will be determined by your doctor based on your condition, which may change over time. It is essential to follow your doctor's instructions precisely.
Uses of Mabtas 500 mg Solution for Infusion:
Non-Hodgkin lymphoma (NHL)
Rheumatoid arthritis
Chronic lymphocytic leukemia (blood cancer)
Granulomatosis with polyangiitis
Microscopic polyangiitis
Benefits of Mabtas 500 mg Solution for Infusion:
In Non-Hodgkin lymphoma (NHL):
Mabtas 500 mg Solution for Infusion stimulates the immune response and helps reduce pain and inflammation associated with NHL. It also eliminates cancer cells and prevents their further growth. Patients are advised to avoid crowded places and maintain good hygiene practices to prevent infections. Adequate fluid intake is recommended unless advised otherwise by the doctor.
In Rheumatoid arthritis:
Mabtas 500 mg Solution for Infusion alleviates inflammation, pain, and swelling in rheumatoid arthritis by suppressing the immune system response. The dosage and frequency will be determined by the doctor. Patients should follow their doctor's instructions carefully and inform them of any fever, chills, or troublesome side effects after taking the medication.
In Chronic lymphocytic leukemia (CLL):
Mabtas 500 mg Solution for Infusion inhibits or stops the growth of cancer cells and prevents their proliferation. Patients should discuss the side effects and benefits of this medication with their doctor and inform them if any side effects bother them.
In Granulomatosis with polyangiitis:
Mabtas 500 mg Solution for Infusion reduces inflammation, pain, and swelling in granulomatosis with polyangiitis, preventing further damage. This contributes to improving the patient's quality of life.
In Microscopic polyangiitis:
Microscopic polyangiitis is an autoimmune disease that affects small blood vessels and may result from immune system issues. Mabtas 500 mg Solution for Infusion reduces the immune response and inflammation, helping to manage this condition and alleviate discomfort.
Mechanism of action of Mabtas 500 mg Solution for Infusion:
Mabtas 500 mg Solution for Infusion is a monoclonal antibody that targets the abnormal activity of immune cells (B cells) in rheumatoid arthritis and certain types of cancers, thereby modulating the immune response.